World
Virus Vaccine May Be Ready for Mass Production By Autumn, Oxford Professor Says
- Trial aims to give experimental shot to 500 people by mid-May
- Data on efficacy ready by the fall in best-case scenario
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
A coronavirus vaccine trial by University of Oxford researchers aims to get efficacy results by September, and manufacturing is already underway.